Erika Carmel-Tech Ltd (TLV:ERKA)

Market Cap	22.21M +14.0%
Revenue (ttm)	37.34M -1.6%
Net Income	-5.85M
EPS	-0.14
Shares Out	41.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,901
Open	53.30
Previous Close	53.30
Day's Range	49.20 - 53.30
52-Week Range	37.50 - 77.50
Beta	1.04
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About Erika Carmel-Tech

Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. The company treats achilles tendon inflammation, burns, carpal tunnel syndrome, finger joint pain, fibromyalgia, hip pain, post-dental treatment, lower ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 45
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ERKA

Financial Performance

In 2025, Erika Carmel-Tech's revenue was 37.34 million, a decrease of -1.64% compared to the previous year's 37.96 million. Losses were -5.85 million, -38.19% less than in 2024.